Veralto Corporation filings document the regulatory record for a Delaware operating company focused on essential water and product quality solutions. Form 8-K reports furnish quarterly and annual operating results, non-GAAP measures, cash flow commentary, completed acquisitions, cost optimization actions and other material events.
Its proxy and governance filings cover annual meeting proposals, director elections, executive compensation and shareholder voting matters. Other current reports address capital-structure actions such as common-stock repurchase authorizations, officer transitions, compensatory arrangements and related governance disclosures.
BlackRock, Inc. filed an amended Schedule 13G reporting its beneficial ownership of Veralto Corp common stock. BlackRock reports beneficial ownership of 20,884,996 shares, representing 8.5% of Veralto’s outstanding common stock.
BlackRock has sole voting power over 19,179,723 shares and sole dispositive power over 20,884,996 shares, with no shared voting or dispositive power. The filing explains that various underlying clients have rights to dividends and sale proceeds, but no single person has an interest exceeding five percent of Veralto’s outstanding common shares.
Jennifer Honeycutt filed to sell 7,097 shares of VLTO common stock through Fidelity Brokerage Services LLC, with an indicated aggregate market value of $720,487.44, on or after July 29, 2026 on the NYSE. The shares relate to a stock option exercise from the issuer for cash. The filing also lists a prior sale of 7,097 shares of common stock on July 17, 2026 for $674,215.00.
Veralto Corp director Thomas Williams reported a quarterly company contribution under the Non-Employee Directors' Deferred Compensation Plan, credited as 183 unfunded, notional shares of common stock on July 24, 2026 at $92.02 per notional share, increasing his deferred account balance to 183 equivalent shares.
Each notional share converts on a one-for-one basis into common stock, with vesting and distribution governed by the plan’s terms and his elections.
Veralto Corp reported that director Cindy L. Wallis-Lage received a quarterly Company contribution under the Veralto Corporation Non-Employee Directors' Deferred Compensation Plan, credited as 38 notional shares of common stock at $92.02 per share on July 24, 2026. These unfunded, notional shares convert one-for-one into common stock, with vesting and distribution governed by the plan and her prior elections.
Veralto Corp reported that director Heath A. Mitts received a quarterly company contribution under the Veralto Corporation Non-Employee Directors' Deferred Compensation Plan, deemed invested in 154.0000 unfunded, notional shares of Veralto common stock as of July 24, 2026 at a reference price of 92.0200 per notional share. Each notional share converts on a one-for-one basis into common stock, with vesting and distribution governed by the plan terms and the director’s elections as described in Veralto’s annual meeting proxy statement.
Veralto Corporation reported stronger results for the three-month period ended July 3, 2026, with sales of $1,474 million, up 7.6% year over year, and net earnings of $241 million, up from $222 million. Gross margin improved to 61.2% driven by pricing, productivity and tariff recoveries. Diluted EPS was $0.98 for the quarter and $2.00 for the first six months on $2,896 million of year‑to‑date sales and $495 million of net earnings.
Water Quality segment sales rose to $908 million in the quarter and $1,782 million year to date, helped by the January acquisition of In‑Situ for $426 million. Product Quality & Innovation delivered $566 million in quarterly sales. Recurring revenue reached $915 million in the quarter and $1,802 million year to date, about 62% of total.
Operating cash flow for the first six months was $522 million. Veralto funded two acquisitions, including GlobalVision for $195 million, issued $725 million of 4.85% senior notes due 2032 and ended with $2,119 million of cash and $3,379 million of debt. The company repurchased $434 million of stock and began a multi‑year 2026 Cost Optimization Program, recording $29 million of restructuring charges toward an expected $85–$105 million total through 2028.
Veralto Corporation reported second quarter 2026 results with sales of $1,474 million, up 7.6% year-over-year, and non-GAAP core sales growth of 4.2%. GAAP net earnings were $241 million, or $0.98 per diluted share, while adjusted net earnings were $274 million, or $1.11 per diluted share, including about $0.05 per share of benefit from IEEPA tariff recoveries.
Operating profit margin was 21.4%, or 24.6% on an adjusted basis. Water Quality delivered 5.7% core sales growth and Product Quality and Innovation 2.0%. Veralto generated $340 million of operating cash flow and $328 million of free cash flow, supported by recent bolt-on acquisitions and share repurchases.
Management guides third quarter 2026 non-GAAP core sales growth to 4.0%–5.0% with adjusted EPS of $1.06–$1.09. For full year 2026, guidance was raised to core sales growth of 4.0%–4.5% and adjusted EPS of $4.35–$4.43, implying 12%–14% year-over-year growth and free cash flow conversion above 100% of GAAP net earnings.
Veralto President and CEO Jennifer Honeycutt exercised 7,097 employee stock options at $28.76 per share on July 17, 2026, receiving 7,097 common shares and selling 7,097 shares at $95.00 per share under a Rule 10b5-1 trading plan, leaving 14,195 options outstanding.
Veralto Corp reported equity awards to director John T. Schwieters on 2026-07-15. He received 1,009 shares of Common Stock, described in a footnote as restricted stock units that vest on the earlier of the first anniversary of the grant date or the next annual shareholder meeting, with underlying shares issued only after specific retirement or death-related timing conditions.
On the same date he was also granted 3,553 Director Stock Options to buy Common Stock at an exercise price of $91.00 per share, which the company states are fully vested as of the grant date and expire on 2036-07-15. After these awards, direct holdings reported are 6,498 shares of Common Stock and 9,413 stock options.
Veralto Corp director Thomas Williams received equity compensation on 2026-07-15. He was granted 1009.0000 restricted stock units tied to common stock, which vest by the next annual shareholder meeting and are issued only after his board service ends. He also received 3553.0000 fully vested director stock options with an exercise price of 91.0000 per share expiring on 2036-07-15, bringing his holdings to 3380.0000 common shares and 9413.0000 options.